0024-5922 : Kevzara 200 mg/1.14ml Subcutaneous Injection, Solution


NDC0024-5922
Labeler: Sanofi-aventis U.S. LLC
Product Type: Human Prescription Drug
Drug Name:  Kevzara
Dosage Form: Subcutaneous Injection, Solution
Application #: BLA761037
Rev. Date: 


NDC Package Codes:

  • 0024-5922-01: 2 SYRINGE IN 1 PACKAGE (0024‑5922‑01) > 1.14 ML IN 1 SYRINGE
  • 0024-5922-02: 2 SYRINGE IN 1 PACKAGE (0024‑5922‑02) > 1.14 ML IN 1 SYRINGE

Active Ingredients:

  • Sarilumab

Dosage Strength:

  • 200 mg/1.14mL

Pharmaceutical Classes:

  • Interleukin 6 Receptor Antagonists [MoA]
  • Interleukin-6 Receptor Antagonist [EPC]

Related Products:

Based on records with the same trade name.
  • 0024-5908 Kevzara 150 mg/1.14ml Subcutaneous Injection, Solution by Sanofi-aventis U.S. LLC
  • 0024-5910 Kevzara 200 mg/1.14ml Subcutaneous Injection, Solution by Sanofi-aventis U.S. LLC
  • 0024-5920 Kevzara 150 mg/1.14ml Subcutaneous Injection, Solution by Sanofi-aventis U.S. LLC

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 0024-5922 QR Code

< Prev: 0024-5920Next: 0024-5924 >




Notice: The MedsChat® NDC Database compiles publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.


Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 11 May 2018.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA